Short paper Endothelial dysfunction of resistance vessels in female apolipoprotein E-deficient mice

Lipids in Health and Disease

Volumn 9, Issue 1, 2010, Pages

  Cola, Maine S ^a   Gava, Agata L ^a   Meyrelles, Silvana S ^a   Vasquez, Elisardo C ^a,b  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; APOLIPOPROTEIN E; CHOLESTEROL; ESTRADIOL; NITROPRUSSIDE SODIUM; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; C57BL 6 MOUSE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; EC50; ENDOTHELIAL DYSFUNCTION; ESTRADIOL BLOOD LEVEL; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HYPERLIPOPROTEINEMIA TYPE 3; MESENTERIC ARTERY; MICROCIRCULATION; MOUSE; NONHUMAN; OVARIECTOMY; RESISTANCE BLOOD VESSEL; SMOOTH MUSCLE RELAXATION; UTERUS WEIGHT; VASODILATATION; ANIMAL; ATHEROSCLEROSIS; C57BL MOUSE; HYPERCHOLESTEROLEMIA; PATHOPHYSIOLOGY; SPLANCHNIC BLOOD FLOW; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; ENDOTHELIUM, VASCULAR; FEMALE; HYPERCHOLESTEROLEMIA; MICE; MICE, INBRED C57BL; OVARIECTOMY; SPLANCHNIC CIRCULATION; VASCULAR RESISTANCE;

EID: 77952310248     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-9-51     Document Type: Article

References (36)

1. Ross R: Atherosclerosis: an inflammatory disease. N Engl J Med 1999, 340:115-126.
2. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N: Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA 1992, 89:4471-4475.
3. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL: Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992, 71:343-353.
4. Meir KS, Leitersdorf E: Atherosclerosis in the apolipoprotein E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol 2004, 24:1006-1014.
5. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809.
6. Gervais M, Pons S, Nicoletti A, Cosson C, Giudicelli J-F, Richer C: Fluvastatin prevents renal dysfunction and vascular NO deficit in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2003, 23:183-189.
7. Villeneuve N, Fortuno A, Sauvage M, Fournier N, Breugnot C, Jacquemin C, Petit C, Gosgnach W, Carpentier N, Vanhoutte P, Vilaine J-P: Persistence of the nitric oxide pathway in the aorta of hypercholesterolemic apolipoprotein E-deficient mice. J Vasc Res 2003, 40:87-96.
8. Deckert V, Lizard G, Duverger N, Athias A, Palleau V, Emmanuel F, Moisant M, Gambert P, Lallemant C, Lagrost L: Impairment of endotheliumdependent arterial relaxation by high-fat feeding in apoE-deficient mice: toward normalization by human apoA-I expression. Circulation 1999, 100:1230-1235.
9. Niebauer J, Maxwell AJ, Lin PS, Tsao PS, Kosek J, Bernstein D, Cooke JP: Impaired aerobic capacity in hypercholesterolemic mice: partial reversal by exercise training. Am J Physiol Heart Circ Physiol 1999, 276:1346-1354.
10. d'Uscio LV, Smith LA, Katusic ZS: Hypercholesterolemia impairs endothelium-dependent relaxations in common carotid arteries of apolipoprotein E-deficient mice. Stroke 2001, 32:2658-2664.
11. Jiang F, Gibson AP, Dusting GJ: Endothelial dysfunction induced by oxidized low-density lipoproteins in isolated mouse aorta: a comparison with apolipoprotein-E deficient mice. Eur J Pharmacol 2001, 424:141-149.
12. Arruda RMP, Peotta VA, Meyrelles SS, Vasquez EC: Evaluation of vascular function in apolipoprotein E knockout mice with angiotensindependent renovascular hypertension. Hypertension 2005, 46:932-936.
13. Wölfle SE, de Wit C: Intact endothelium-dependent dilation and conducted responses in resistance vessels of hypercholesterolemic mice in vivo. J Vasc Res 2005, 42:475-482.
14. Kitayama J, Faraci FM, Lentz SR, Heistad DD: Cerebral vascular dysfunction during hypercholesterolemia. Stroke 2007, 38:2136-2141.
15. Mendelsohn ME: Mechanisms of estrogen action in the cardiovascular system. J Steroid Biochem Mol Biol 2000, 74:337-343.
16. Arnal J-F, Bayard F: Vasculoprotective effects of oestrogens. Clin Exp Pharmacol Physiol 2001, 28:1032-1034.
17. Tostes RC, Nigro D, Fortes ZB, Carvalho MHC: Effects of estrogen on the vascular system. Braz J Med Biol Res 2003, 36:1143-1158.
18. Maturana MA, Irigoyen MC, Spritzer PM: Menopause, estrogens, and endothelial dysfunction: current concepts. Clinics 2007, 62:77-86.
19. Carr MC, Kim KH, Zambon A, Mitchell ES, Woods NF, Casazza CP, Purnell JQ, Hokanson JE, Brunzell JD, Schwartz RS: Changes in LDL density across the menopausal transition. J Investig Med 2000, 48:245-250.
20. Chae CU, Ridker PM, Manson JE: Postmenopausal hormone replacement therapy and cardiovascular disease. Thromb Haemost 1997, 78:770-780.
21. Qiao X, McConnell KR, Khalil RA: Sex steroids and vascular responses in hypertension and aging. Gend Med 2008, 5:S46-S64.
22. Dantas APV, Scivoletto R, Fortes ZB, Nigro D, Carvalho MHC: Influence of female sex hormones on endothelium-derived vasoconstrictor prostanoid generation in microvessels of spontaneously hypertensive rats. Hypertension 1999, 34:914-919.
23. Molsiri K, Khemapech S, Patumraj S, Siriviriyakul P: Preventive mechanism of genistein on coronary endothelial dysfunction in ovariectomized rats: an isolated arrested heart model. Clin Hemorheol Microcirc 2004, 31:59-66.
24. Stice JP, Eiserich JP, Knowlton AA: Role of aging versus the loss of estrogens in the reduction in vascular function in female rats. Endocrinology 2009, 150:212-219.
25. d'Uscio LV, Barton M, Shaw S, Lüscher TF: Chronic ETA receptor blockade prevents endothelial dysfunction of small arteries in apolipoprotein Edeficient mice. Cardiovasc Res 2002, 53:487-495.
26. Leinwand LA: Sex is a potent modifier of the cardiovascular system. J Clin Invest 2003, 112:302-307.
27. Rodin MB, Daviglus ML, Wong GC, Liu K, Garside DB, Greenland P, Stamler J: Middle age cardiovascular risk factors and abdominal aortic aneurysm in older age. Hypertension 2003, 42:61-68.
28. Blanchard JF, Armenian HK, Friesen PP: Risk factors for abdominal aortic aneurysm: results of a case-control study. Am J Epidemiol 2000, 151:575-583.
29. Marsh MM, Walker VR, Curtiss LK, Banka CL: Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice. J Lipid Res 1997, 40:893-900.
30. Hodgin JB, Krege JH, Reddick RL, Korach KS, Smithies O, Maeda N: Estrogen receptor ? is a major mediator of 17?-estradiol's atheroprotective effects on lesion size in ApoE-/-mice. J Clin Invest 2001, 107:333-340.
31. Henriques TA, Huang J, D'Souza SS, Daugherty A, Cassis LA: Orchidectomy, but not ovariectomy, regulates angiotensin II-induced vascular diseases in apolipoprotein E-deficient mice. Endocrinology 2004, 145:3866-3872.
32. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S: Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 1994, 91:5212-5216.
33. Jun SS, Chen Z, Pace MC, Shaul PW: Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium. J Clin Invest 1998, 102:176-183.
34. Ospina JA, Krause DN, Duckles SP: 17?-Estradiol increases rat cerebrovascular prostacyclin synthesis by elevating cyclooxygenase-1 and prostacyclin synthase. Stroke 2002, 33:600-605.
35. Caligiuri G, Nicoletti A, Zhou X, Törnberg I, Hansson GK: Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice. Atherosclerosis 1999, 145:301-308.
36. Douglas G, Cruz MN, Poston L, Gustafsson J-A, Kublickiene K: Functional characterization and sex differences in small mesenteric arteries of the estrogen receptor-? knockout mouse. Am J Physiol Regul Integr Comp Physiol 2008, 294:112-120.